{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:06:24Z","timestamp":1790665584754,"version":"4.1.0"},"reference-count":30,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Limited macrolide and fluoroquinolone resistance data are available in France for <jats:italic>Mycoplasma genitalium<\/jats:italic>. We performed a multicentre cross-sectional study to investigate the prevalence of macrolide and fluoroquinolone resistance-associated mutations in <jats:italic>M. genitalium<\/jats:italic>-positive patients in metropolitan France between 2018 and 2020 and in overseas France in 2018 and 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Each year, a 1-month prospective collection of <jats:italic>M. genitalium<\/jats:italic>-positive specimens was proposed to metropolitan French microbiology diagnostic laboratories, and a similar 3-month collection was proposed to overseas French laboratories. Resistance-associated mutations were detected using commercial kits and sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1630 <jats:italic>M<\/jats:italic>. <jats:italic>genitalium<\/jats:italic>-positive specimens were analysed. In metropolitan France, the prevalence of macrolide resistance-associated mutations ranged between 34.7% (95% CI 29.4% to 40.4%) and 42.9% (95% CI 37.1% to 49.0%) between 2018 and 2020 and was significantly higher in men (95% CI 52.4% to 60.2%) than in women (95% CI 15.9% to 22.2%) (p&lt;0.001). These prevalences were significantly higher than those of 6.1% (95% CI 3.7% to 10.3%) and 14.7% (95% CI 10.9% to 19.6%) observed in overseas France in 2018 and 2019 (p&lt;0.001), where no difference between genders was noted. The prevalence of fluoroquinolone resistance-associated mutations was also significantly higher in metropolitan France (14.9% (95% CI 11.2% to 19.5%) to 16.1% (95% CI 12.1% to 21.2%)) than in overseas France (1.3% (95% CI 0.4% to 3.7%) and 2.6% (95% CI 1.3% to 5.3%) in 2018 and 2019, respectively) (p&lt;0.001), with no difference between men and women regardless of the location.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study reports the high prevalence of macrolide and fluoroquinolone resistance-associated mutations in <jats:italic>M. genitalium<\/jats:italic> in metropolitan France and highlights the contrast with low prevalence in overseas France. In metropolitan France, macrolide resistance-associated mutation prevalence was three times higher in men than in women, which was likely to be driven by the proportion of men who have sex with men. This suggests that gender and sexual practice should also be taken into account for the management of <jats:italic>M. genitalium<\/jats:italic> infections.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2022-055466","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:21:54Z","timestamp":1662398514000},"page":"sextrans-2022-055466","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of macrolide and fluoroquinolone resistance-associated mutations in <i>Mycoplasma genitalium<\/i> in metropolitan and overseas France"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-4206","authenticated-orcid":false,"given":"Sabine","family":"Pereyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laurier-Nadali\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Le Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guiraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Dolzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege","family":"H\u00e9nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gardette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9b\u00e9ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"2022090510201597000_sextrans-2022-055466v1.1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2018-053831"},{"key":"2022090510201597000_sextrans-2022-055466v1.2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7005a1"},{"key":"2022090510201597000_sextrans-2022-055466v1.3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17972"},{"key":"2022090510201597000_sextrans-2022-055466v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30154-7"},{"key":"2022090510201597000_sextrans-2022-055466v1.5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0956462419890737","article-title":"Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review","volume":"31","author":"Fern\u00e1ndez-Huerta","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2022090510201597000_sextrans-2022-055466v1.6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2209.160446"},{"key":"2022090510201597000_sextrans-2022-055466v1.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06193-6","article-title":"Prevalence and risk factors of Mycoplasma genitalium infection in patients attending a sexually transmitted infection clinic in Reunion Island: a cross-sectional study (2017-2018)","volume":"21","author":"Begnis","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2022090510201597000_sextrans-2022-055466v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks263"},{"key":"2022090510201597000_sextrans-2022-055466v1.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198355"},{"key":"2022090510201597000_sextrans-2022-055466v1.10","doi-asserted-by":"crossref","first-page":"377-383","DOI":"10.1016\/j.jiac.2021.11.011","article-title":"Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains","volume":"28","author":"Hamasuna","year":"2022","journal-title":"J Infect Chemother"},{"key":"2022090510201597000_sextrans-2022-055466v1.11","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161745"},{"key":"2022090510201597000_sextrans-2022-055466v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz550"},{"key":"2022090510201597000_sextrans-2022-055466v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.5.742"},{"key":"2022090510201597000_sextrans-2022-055466v1.14","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413502008"},{"key":"2022090510201597000_sextrans-2022-055466v1.15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01956-12"},{"key":"2022090510201597000_sextrans-2022-055466v1.16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(20)30727-1","article-title":"Macrolide consumption and resistance in Mycoplasma genitalium","volume":"20","author":"Kenyon","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2022090510201597000_sextrans-2022-055466v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054897"},{"key":"2022090510201597000_sextrans-2022-055466v1.18","doi-asserted-by":"crossref","first-page":"e01555","DOI":"10.1128\/JCM.01555-18","article-title":"Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines","volume":"57","author":"Sweeney","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2022090510201597000_sextrans-2022-055466v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2019.03.007"},{"key":"2022090510201597000_sextrans-2022-055466v1.20","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054070"},{"key":"2022090510201597000_sextrans-2022-055466v1.21","doi-asserted-by":"publisher","DOI":"10.3201\/eid2504.181258"},{"key":"2022090510201597000_sextrans-2022-055466v1.22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/dkaa410","article-title":"Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France","volume":"76","author":"Guiraud","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2022090510201597000_sextrans-2022-055466v1.23","unstructured":"Jensen S . Management of Mycoplasma genitalium infection in the era of emerging resistance. 28th European Congress of Clinical Microbiology and Infectious Disease, Madrid, Spain, 2018."},{"key":"2022090510201597000_sextrans-2022-055466v1.24","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001095"},{"key":"2022090510201597000_sextrans-2022-055466v1.25","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001035"},{"key":"2022090510201597000_sextrans-2022-055466v1.26","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2018-053823"},{"key":"2022090510201597000_sextrans-2022-055466v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy025"},{"key":"2022090510201597000_sextrans-2022-055466v1.28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10096-020-04061-w","article-title":"Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands","volume":"40","author":"Nijhuis","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022090510201597000_sextrans-2022-055466v1.29","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001257","article-title":"Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: evaluation of a multiplex real-time PCR assay","volume":"70","author":"Bodiyabadu","year":"2021","journal-title":"J Med Microbiol"},{"key":"2022090510201597000_sextrans-2022-055466v1.30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3201\/eid2602.190533","article-title":"Mycoplasma genitalium antimicrobial resistance in community and sexual health clinic patients, Auckland, New Zealand","volume":"26","author":"Vesty","year":"2020","journal-title":"Emerg Infect Dis"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2022-055466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:22:05Z","timestamp":1662398525000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2022-055466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":30,"alternative-id":["10.1136\/sextrans-2022-055466"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2022-055466","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}